Search
for

    Glossary Cutaneous Lupus Erythematosus Disease Area and Severity Index

    tool to measure skin severity in cutaneous lupus erythematosus

    The Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) is a tool used by healthcare professionals to assess the severity and extent of skin involvement in patients with cutaneous lupus erythematosus. It quantifies both the activity (such as redness and scaling) and damage (like scarring and pigment changes) of the disease, helping to guide treatment decisions and monitor disease progression.

    Related Terms

    Sort by

    Research 30 of 1000+

    1. Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures Journal of the American Academy of Dermatology · 2012 · 40 citations
    2. Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI Journal of the European Academy of Dermatology and Venereology · 2010 · 19 citations
    3. Outcome Measures in Cutaneous Autoimmune Disease: Dermatomyositis and Lupus Erythematosus Technical report · 2006 · 2 citations
    4. Overview of common, rare and atypical manifestations of cutaneous lupus erythematosus and histopathological correlates Lupus · 2010 · 157 citations
    5. Skin Elsevier eBooks · 2011 · 2 citations
    6. Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus Dermatologic Therapy · 2007 · 52 citations
    7. Acknowledging the Clinical Heterogeneity of Lupus Erythematosus 2015
    8. Anifrolumab for systemic lupus erythematosus: A clinical study of Japanese patients in Kanazawa University Hospital The Journal of Dermatology · 2023 · 5 citations
    9. Update on Outcome Measures for Pediatric Systemic Lupus Erythematosus Arthritis Care & Research · 2020 · 3 citations
    10. Skin involvement in systemic lupus erythematosus: a review article Revista română de reumatologie · 2023
    11. All Subcomponents of the Cutaneous Lupus Erythematosus Disease Area and Severity Index–Activity (CLASI-A) are Relevant to Identify and Detect Changes in Skin Activity SKIN The Journal of Cutaneous Medicine · 2026
    12. Trichoscopic signs in systemic lupus erythematosus: a comparative study with 109 patients and 305 healthy controls Journal of the European Academy of Dermatology and Venereology · 2019 · 29 citations
    13. Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist The Journal of Rheumatology · 2022 · 11 citations
    14. Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment Veterinary Dermatology · 2010 · 21 citations
    15. Cutaneous Lupus Erythematosus Dalhousie Medical Journal · 2013
    16. The Link Between Obesity and the Skin Frontiers in Nutrition · 2022 · 12 citations
    17. Hair and Scalp Changes in Cutaneous and Systemic Lupus Erythematosus American Journal of Clinical Dermatology · 2018 · 46 citations
    18. LP-058 The involvement of scalp and nails in cutaneous lupus erythematosus patients: a retrospective study 2023
    19. Cutaneous Lesions in Systemic Lupus Erythematosus Medical Clinics of North America · 1989 · 32 citations
    20. Cutaneous Lupus Erythematosus Springer eBooks · 2017
    21. Non-invasive Approaches for the Diagnosis of Autoimmune/Autoinflammatory Skin Diseases—A Focus on Psoriasis and Lupus erythematosus Frontiers in Immunology · 2019 · 17 citations
    22. Topical use of systemic drugs in dermatology: A comprehensive review 2011 · 19 citations
    23. 12. Cancer Journal of Cutaneous Medicine and Surgery · 2003
    24. The influence of interferon on healthy and diseased skin Cytokine · 2018 · 32 citations
    25. Quality of life in cutaneous lupus erythematosus Journal of the American Academy of Dermatology · 2011 · 158 citations
    26. POS0548 ACUTE AND SUBACUTE SKIN MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS ARE ASSOCIATED WITH AN EARLIER RESPONSE TO BELIMUMAB THAN THE CHRONIC PHENOTYPE: PRELIMINARY DATA FROM THE NEW NATION-WIDE COHORT OF BELIMUMAB IN REAL LIFE SETTING STUDY—NEW JOINT AND SKIN (BERLISS-NEJS) 2024
    27. A review of cutaneous lupus erythematosus: improving outcomes with a multidisciplinary approach Journal of Multidisciplinary Healthcare · 2019 · 26 citations
    28. British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021 British Journal of Dermatology · 2021 · 20 citations
    29. Measures of Adult Systemic Lupus Erythematosus: Disease Activity and Damage Arthritis Care & Research · 2020 · 44 citations
    30. Dermoscopy in General Dermatology: A Practical Overview Dermatology and Therapy · 2016 · 243 citations